What is the Projected CAGR value of the Neurodegenerative Disease Market?
Neurodegenerative Disease Market is expected to grow at a CAGR of 7.4% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
Major players are AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA and Novartis.